Pilot Analysis of unbound sorafenib: relevance to efficacy and toxicity in a Phase I trial and to in-vitro cytotoxicity
|Effective start/end date||11/1/12 → 10/31/14|
- MN MED FDN
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.